| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/03/2006 | WO2006080439A1 Tricyclic compound |
| 08/03/2006 | WO2006080430A1 Ophthalmic medicine composition |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2006079476A1 Phantom phenomena treatment |
| 08/03/2006 | WO2006079217A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | WO2006044421A3 Cardiac safe, rapid medication delivery |
| 08/03/2006 | WO2006033734A3 Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders |
| 08/03/2006 | WO2005099715A3 Treatment of ophthalmic conditions with mineralcorticoids |
| 08/03/2006 | US20060172985 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172969 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | CA2595942A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1684790A2 Homogeneous preparations of chimeric proteins |
| 08/02/2006 | EP1684756A1 Cytokine inhibitory drugs for treatment of macular degeneration |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP1163274B1 Process for cross-linking hyaluronic acid to polymers |
| 08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | EP1001785B1 Use of colchinol derivatives as vascular damaging agents |
| 08/02/2006 | CN1810272A Prepn process of red sage prepn and its quality control method |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267407C Prodrugs of excitatory amino acids |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267150C Eye drops |
| 08/02/2006 | CN1267121C Eye disease treating medicine and its preparing process |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 08/02/2006 | CN1267087C Pharmaceutical tablet |
| 08/01/2006 | US7084157 Antiinflammatory agents; vision defects; antiallergens; topical applying |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | US7084128 Administering purinerginic receptor ligand, which is a mononucleoside polyphosphate or dinucleoside polyphosphate such as di-5'-((2'O-benzyl)adenosine)tetraphosphate; for treatment of glaucoma |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083803 Ocular solutions |
| 08/01/2006 | US7083802 Using rapamycin |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |
| 08/01/2006 | CA2277990C 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/27/2006 | WO2006077824A1 Drugs for nerve cell regeneration |
| 07/27/2006 | WO2006077168A1 Pyrazolopyridines, their preparation and their medical use |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167003 Probucol derivatives |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166956 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166930 Pharmaceutical composition for dry eye, which remains on the cornea and exhibits a humectant effect for a longer period |
| 07/27/2006 | US20060163393 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard |
| 07/27/2006 | CA2595004A1 Remedy for nerve cell regeneration |
| 07/26/2006 | EP1683805A1 Novel inhibitor for advanced glycation endproduct formation and aldose reductase inhibitor |
| 07/26/2006 | EP1683798A1 Novel fused polycyclic compound having heterocycle and medicinal use thereof |
| 07/26/2006 | EP1683796A1 Pyrazolopyridines, their preparation and their medical use |
| 07/26/2006 | EP1682498A1 Novel prostamides for the treatment of glaucoma and related diseases |
| 07/26/2006 | EP1682122A1 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic |
| 07/26/2006 | EP1527063B1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1414447B1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 07/26/2006 | EP1397105B1 Compositions for inhibiting angiogenesis |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1266126C Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/26/2006 | CN1265803C Balsam pear frost eye medicament for preventing and treating cataract and vision fatigue |
| 07/25/2006 | US7081482 Therapy of disorders of the outer retina by administering a pharmaceutically effective amount of a beta -adrenoceptor antagonist |
| 07/25/2006 | US7081469 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/25/2006 | CA2283663C Benzocycloheptathiophene compounds |
| 07/25/2006 | CA2186245C Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/20/2006 | WO2006075748A1 Therapeutic agent for allergic conjunctival disease |
| 07/20/2006 | WO2006075020A2 Ampa antagonist for the treatment of dizziness, including vertigo and meniere's disorder |
| 07/20/2006 | WO2006074872A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | WO2006074495A1 Substance mixture |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160818 Ocular hypotensive agent |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | DE102005001989A1 Intravenöse Formulierungen von PDE-Inhibitoren Intravenous formulations of PDE inhibitors |
| 07/20/2006 | CA2594709A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | CA2594101A1 Substance mixture |
| 07/20/2006 | CA2593661A1 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |